سعر ريليستات 0.05% قطرة للعين 5مل 2022

Epinastine hydrochloride 0.05% (0.5 mg/ml) eye drops, a topical H1-receptor antagonist with mast-cell stabilising activity, for allergic conjunctivitis.

• Treatment of the symptoms of seasonal allergic conjunctivitis.Population: Adults and adolescents 12 years and olderelectronic medicines compendium (emc)
• Prevention of itching associated with allergic conjunctivitis.DailyMed (NLM)

• Common: burning sensation and eye irritation. Uncommon: headache, conjunctival/ocular hyperaemia, eye discharge, dryness, pruritus, visual disturbance, asthma, nasal irritation, rhinitis, dysgeusia. Not known: hypersensitivity including angioedema, increased lacrimation, eye pain/swelling, eyelid oedema.International label, same formulation · electronic medicines compendium (emc)
• Ocular (about 1-10%): burning sensation, folliculosis, hyperaemia, pruritus; non-ocular: cold symptoms/upper respiratory infection (about 10%), headache, rhinitis, sinusitis, cough, pharyngitis.International label, same formulation · DailyMed (NLM)

• Hypersensitivity to the active substance or any excipient.International label, same formulation · electronic medicines compendium (emc)

• Contains benzalkonium chloride: may cause punctate or toxic ulcerative keratopathy and eye irritation; remove soft contact lenses before use and reinsert after 15 minutes; caution in dry eye or compromised cornea.International label, same formulation · electronic medicines compendium (emc)
• Contains phosphates: very rare corneal calcification reported in patients with significantly damaged corneas.International label, same formulation · electronic medicines compendium (emc)
• Do not use to treat contact lens-related irritation; do not wear contact lenses if the eye is red.International label, same formulation · DailyMed (NLM)

• Other medicinal productsNo interaction studies performed; no drug-drug interactions anticipated because systemic concentrations after ocular dosing are extremely low.electronic medicines compendium (emc)

• Limited data (11 exposed pregnancies) show no adverse effects; animal studies show no harm; caution should be exercised when prescribing to pregnant women.International label, same formulation · electronic medicines compendium (emc)
• No adequate well-controlled studies in pregnant women; use only if the potential benefit justifies the potential risk to the fetus.International label, same formulation · DailyMed (NLM)
• Excreted in rat milk; unknown in humans; caution in breast-feeding women.International label, same formulation · electronic medicines compendium (emc)

• Epinastine hydrochloride: Topically active direct H1-receptor antagonist (400-fold lower H2 affinity) with mast-cell stabilising activity; does not cross the blood-brain barrier.